Therapy Areas: Respiratory
15 October 2021 - - US-based clinical-stage company Tizona Therapeutics, Inc's lead investigational therapy, TTX-080, a novel antibody targeting HLA-G, has advanced to Phase 1b, the company said....
15 October 2021 - - US-based Exelixis, Inc. (NASDAQ: EXEL) has exercised its exclusive option under its July 2019 agreement with Aurigene Discovery Technologies Ltd. to in-license XL114 (formerly...
15 October 2021 - Biopharmaceutical company Medigen Vaccine Biologics Corporation on Friday published data from its MVC-COV1901 vaccine phase 2 clinical trial demonstrating promising immunogenicity an...
13 October 2021 - - Brukinsa (zanubrutinib) has been approved in Australia for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy, Chinese biotechno...
11 October 2021 - - UK-based biopharmaceutical company AstraZeneca's (NASDAQ: AZN) Tezepelumab has been granted Orphan Drug Designation in the US by the Food and Drug Administration for the treat...
8 October 2021 - - US-based biotechnology company Lassen Therapeutics has appointed an industry executive and clinical thought leaders to its team, the company said.

Lisa Olson, Ph.D., jo...
Related Headlines